![Centro di riferimento per il coordinamento regionale delle sindromi talassemiche-emoglobinopatich... | Policlinico di Milano Centro di riferimento per il coordinamento regionale delle sindromi talassemiche-emoglobinopatich... | Policlinico di Milano](https://www.policlinico.mi.it/assets/fom/cache/news/news_m/2863/images/top/6640/zyro-image__1__95ed123cf006e3e405499e9335e325d2.jpg)
Centro di riferimento per il coordinamento regionale delle sindromi talassemiche-emoglobinopatich... | Policlinico di Milano
Maria Domenica Cappellini, MD, FRCP, FACP University of Milan, Milan, Italy Fondazione IRCCS Policlinico Hospital , Mila
![PDF) Non-transferrin-bound iron negatively correlates with red cell glutathione in beta-thalassemia intermedia. PDF) Non-transferrin-bound iron negatively correlates with red cell glutathione in beta-thalassemia intermedia.](https://i1.rgstatic.net/publication/296222053_Non-transferrin-bound_iron_negatively_correlates_with_red_cell_glutathione_in_beta-thalassemia_intermedia/links/5bf29ec3a6fdcc3a8de138ae/largepreview.png)
PDF) Non-transferrin-bound iron negatively correlates with red cell glutathione in beta-thalassemia intermedia.
![Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of Myocardial Performance Index – topic of research paper in Medical engineering. Download scholarly article PDF and read for free Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of Myocardial Performance Index – topic of research paper in Medical engineering. Download scholarly article PDF and read for free](https://cyberleninka.org/viewer_images/1126897/f/1.png)
Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of Myocardial Performance Index – topic of research paper in Medical engineering. Download scholarly article PDF and read for free
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic eryth
![EHA 2022: Effects of Luspatercept on Need for Red Blood Cell Transfusions are Sustained in Patients with β-Thalassemia | PracticeUpdate EHA 2022: Effects of Luspatercept on Need for Red Blood Cell Transfusions are Sustained in Patients with β-Thalassemia | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/36332.jpg)
EHA 2022: Effects of Luspatercept on Need for Red Blood Cell Transfusions are Sustained in Patients with β-Thalassemia | PracticeUpdate
![PDF) Quality of life in patients with beta‐thalassemia: a prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand | Abderrahmane Laadem - Academia.edu PDF) Quality of life in patients with beta‐thalassemia: a prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand | Abderrahmane Laadem - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/74492445/mini_magick20211110-27373-6842dw.png?1636559185)
PDF) Quality of life in patients with beta‐thalassemia: a prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand | Abderrahmane Laadem - Academia.edu
![Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome - Papo - 1999 - British Journal of Haematology - Wiley Online Library Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome - Papo - 1999 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/58fb1ad9-676f-40e6-a2a3-e21f282bceae/j.1365-2141.1999.1331e.x.fp.png)
Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome - Papo - 1999 - British Journal of Haematology - Wiley Online Library
![PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload | Gian Forni - Academia.edu PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload | Gian Forni - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47565905/mini_magick20220703-27682-3bxc5b.png?1656854310)